The amyloid- protein precursor (APP) is a type I transmembrane molecule that undergoes several finely regulated cleavage events. The physiopathological relevance of APP derives from the fact that its aberrant processing strongly correlates with the onset of Alzheimer's disease (AD). AD is a neurodegenerative disorder characterized by neuronal cell death, loss of synapses, and deposition of misfolded protein plaques in the brain; the main constituent of these plaques is the amyloid- peptide, a 40 -42 amino-acid-long protein fragment derived by APP upon two sequential processing events. Mutations in the genes encoding for APP and some of the enzymes responsible for its processing are strongly associated with familial forms of early onset AD. Therefore, the elucidation of the mechanisms underlying APP metabolism appears crucial to understanding the basis for the onset of AD. Apart from A, upon processing of APP other fragments are generated. The long extracellular domain is released in the extracellular space, whereas the short cytoplasmic tail, named APP intracellular domain (AID) is released intracellularly. AID appears be involved in several cellular processes, apoptosis, calcium homeostasis, and transcriptional regulation. We have recently reported the cloning and characterization of different isoforms of AID associated protein-1 (AIDA-1), a novel AID-binding protein. Here we further analyzed the interaction between several AIDA-1 isoforms and the cytoplasmic tail of APP. Our data demonstrated that the interaction between the two molecules is regulated by alternative splicing of the AIDA-1 proteins. Furthermore, we provide data supporting a possible function for AIDA-1a as a modulator of APP processing.Alzheimer's disease is a neuropathological disorder characterized by dementia, memory loss, neuronal apoptosis, and, eventually, death of the affected individuals (1). Studies on familial forms of Alzheimer's disease revealed the crucial role played by mutations in genes encoding for APP 1 and presenilins in the pathogenesis of the disease (2-9). Presenilins are part of the ␥-secretasome, an enzymatic complex responsible for the intramembranous proteolysis of several transmembrane receptors, among which is APP (10 -20). Other enzymes, named -and ␣-secretases, cleave APP in its extracellular region releasing soluble N-terminal fragments (21, 22). The above-mentioned mutations in presenilins and APP are the genetic basis for familial forms of Alzheimer's disease, and they all result in aberrant processing of APP (10,(23)(24)(25). A lot of scientific interest has been more recently focused on studying potential functions for the intracellular domain of APP (AID), which is released upon cleavage by ␥-secretase. AID has been shown to be a pro-apoptotic molecule (26), to play a role in intracellular calcium homeostasis (27), to inhibit Notch signaling (28), and to be required for the activation and potential transcriptional activity of the adaptor proteins Fe65 (29,30) and Jun N-terminal kinase inter...